TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) ha annunciato la presentazione di nuovi dati su Enspryng® (nome generico: satralizumab [ricombinazione genetica]) riguardo alla riduzione della gravità delle recidive nel trattamento …
Category: Business
New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse in Neuromyelitis Optica Spectrum Disorder (NMOSD)
TOKYO–(BUSINESS WIRE)– #NMOSD–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced the presentation of new Enspryng® (generic name: satralizumab [genetical recombination]) data on reducing relapse severity in the treatment of neuromyelitis optica …
Lineage Cell Therapeutics and AgeX Therapeutics Announce Expansion of Agreement Related to ESI Clinical-Grade Pluripotent Stem Cell Lines for Therapeutic Purposes
CARLSBAD, Calif. & ALAMEDA, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, ES Cell International Pt…
New Preclinical Study Finds Niagen® Prevents Light-Induced Retinal Damage in Mice
LOS ANGELES–(BUSINESS WIRE)—- $CDXC #CellularHealth–ChromaDex Corp. (NASDAQ:CDXC) today announced new preclinical research published in Investigative Ophthalmology & Visual Science finding Niagen® (patented nicotinamide riboside, or NR) prevent…
NextGen Healthcare, Inc. to Present at Upcoming Investor Conferences
IRVINE, Calif.–(BUSINESS WIRE)—- $NXGN #AmbulatoryHealthcare–NextGen Healthcare announced that President and CEO, Rusty Frantz and CFO, Jamie Arnold, will participate in upcoming investor conferences.
Optics Balzers : le filtre variable linéaire – une solution flexible pour l'acquisition des données dans le cadre des technologies de laboratoire
BALZERS, Liechtenstein–(BUSINESS WIRE)–L’actuelle pandémie de SARS-CoV-2 prouve très clairement combien il est essentiel que les laboratoires d’analyse déterminent les résultats avec rapidité et précision. Même avant que la pandémie n’éclate, les équ…
Riassunto: Optics Balzers: Linear Variable Filter – una soluzione flessibile per l'acquisizione di dati nella tecnologia di laboratorio
BALZERS, Liechtenstein–(BUSINESS WIRE)–L’attuale pandemia da SARS-CoV-2 ha reso oltremodo evidente quanto è importante determinare i valori delle analisi di laboratorio in modo rapido e accurato. Tuttavia, anche nel periodo precedente all’insorgere d…
Lineage Cell Therapeutics Awarded Grant From Israel Innovation Authority for Development of a Bio-Retinal Patch for Treatment of Retinal Diseases in Partnership With Precise Bio
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that the Company has been …
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that members of its ma…
Resumen: Optics Balzers: Linear Variable Filter, una solución flexible para la adquisición de datos en la tecnología de laboratorio
BALZERS, Liechtenstein–(BUSINESS WIRE)–La actual pandemia de SARS-CoV-2 ha puesto de manifiesto la importancia de determinar con rapidez y precisión los valores analíticos de laboratorio. Sin embargo, incluso en los días anteriores al inicio de la pa…
Samenvatting: Optics Balzers: lineaire variabele filter – een flexibele oplossing voor data-acquisitie in laboratoriumtechnologie
BALZERS, Liechtenstein–(BUSINESS WIRE)–De huidige SARS-CoV-2 pandemie heeft overduidelijk gemaakt hoe belangrijk het is om analytische laboratoriumwaarden snel en nauwkeurig te bepalen. Maar zelfs in de dagen voordat de pandemie uitbrak, was er al ee…
Research Report: Optical Coherence Tomography For Ophthalmology Market (2020-2024) | The Increasing Incidences Of Ocular Diseases to boost the Market Growth | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOpticalCoherenceTomographyforOphthalmologyMarket–The Global Optical Coherence Tomography for Ophthalmology Market will grow by USD 302.3 mn during 2020-2024
National Vision Holdings, Inc. Announces Participation in the Goldman Sachs 27th Annual Global Retailing Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced the Company is scheduled to participate in a virtual fireside chat at the Goldman Sachs 27th Annual Global Retailing Conference on Wednesday, September 9, 2020 a…
Aldeyra to Participate in Citi’s 15th Annual BioPharma Virtual Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and Chief Executive Officer Todd C. Brady, M.D., Ph.D., will participate in an ophthalmology panel discussion during Citi’s 15th Annua…
Groundbreaking EnChroma Lens Technology Addresses Low Vision and Age-Related Eye Conditions
BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–Groundbreaking EnChroma Glasses Address Low Vision & Age-Related Eye Conditions; Superior Glare Reduction, Comfort, Color, Contrast & Improved Vision
IVERIC bio to Participate in Upcoming September Investor / Industry Conferences
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that the Company will participate in the two upcoming virtual investor conferences and a retina showcase conference in September.
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today an…
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio granted two newly hired, non-executive employees a non-statutory stock option to purchase 34,000 shares of the Company’s common stock.
STAAR Surgical to Participate in Upcoming Investor Conferences
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that management will participate in several up…
Covenant Physician Partners Announces Two Executive Appointments
NASHVILLE, Tenn.–(BUSINESS WIRE)–Covenant Physician Partners (Covenant) today announced two executive appointments in the first half of 2020. Chad Baldwin has joined the company as Executive Vice President and Chief Development Officer and Phyllis Sm…